BIO logo

BIO

Bio-Rad Laboratories Inc. Class A

$282.44
-$2.23(-0.78%)
54
Overall
75
Value
45
Tech
42
Quality
How is this score calculated?
Market Cap
$7.76B
Volume
402.77K
52W Range
$222.80 - $343.12
Target Price
$301.25

Company Overview

Mkt Cap$7.76BPrice$282.44
Volume402.77KChange-0.78%
P/E Ratio10.2Open$284.61
Revenue$2.6BPrev Close$284.67
Net Income$759.9M52W Range$222.80 - $343.12
Div YieldN/ATarget$301.25
Overall54Value75
Quality42Technical45

No chart data available

About Bio-Rad Laboratories Inc. Class A

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Sector: Healthcare
Industry: Diagnostics & Research

Latest News

3 Best Healthcare Stocks to Buy in June, According to Analysts

Healthcare stocks are in focus this month as investors look for steady growth and clear catalysts in a market dealing with volatility and uneven se...

Radhika Saraogi21 hours ago

3 Best Healthcare Stocks to Buy in June, According to Analysts

Radhika Saraogia day ago

BioAge Moves BGE-102 Into Mid-Stage Obesity Heart-Risk Trial, Raising New Investor Focus

TipRanks Clinical-Trials-Auto-Generated Newsdesk2 days ago

Valion Bio Completes New Preferred Stock Financing Round

TipRanks Auto-Generated Newsdesk2 days ago

Orchestra BioMed Holdings (OBIO) Gets a Hold from BTIG

TipRanks Auto-Generated Intelligence Newsdesk3 days ago
ABCD
1SymbolPriceChangeVol
2BIO$282.44-0.8%402.77K
3
4
5
6

Get Bio-Rad Laboratories Inc. Class A Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.